Home > Protocol Summaries: Compounds > GSK1362885 Protocol Summaries: GSK1362885 GSKStudy ID Phase Title Status 111497 phase 1 A single-blind, randomized, placebo controlled, ascending single dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of GSK1362885 in healthy normal subjects. Completed 111823 phase 1 A Randomized, Open-Label Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Pharmacodynamics ofGSK1362885 in Subjects with Type 2 Diabetes Mellitus Completed
